Avoro Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $6.86 Billion
- Q4 2024
A detailed history of Avoro Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 12,222,222 shares of APLS stock, worth $297 Million. This represents 5.68% of its overall portfolio holdings.
Number of Shares
12,222,222
Previous 11,111,111
10.0%
Holding current value
$297 Million
Previous $320 Million
21.71%
% of portfolio
5.68%
Previous 4.82%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
301Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$288 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$244 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$234 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$141 Million0.01% of portfolio
-
State Street Corp Boston, MA4.53MShares$110 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.67B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...